Hemicholinium-3

Hemicholinium-3 (HC-3) is a chemical compound that acts as an inhibitor of the high-affinity choline transporter (CHT1). It is primarily used in neuroscience research to study the role of acetylcholine in the nervous system.
Mechanism of Action[edit]
Hemicholinium-3 inhibits the uptake of choline into the presynaptic terminal of cholinergic neurons. By blocking the high-affinity choline transporter, HC-3 reduces the availability of choline for the synthesis of acetylcholine. This leads to a decrease in acetylcholine production and release, thereby affecting cholinergic neurotransmission.
Applications in Research[edit]
HC-3 is widely used in research to investigate the function of cholinergic systems in the brain and peripheral nervous system. It helps in understanding the role of acetylcholine in various physiological and pathological processes, including memory, learning, and neurodegenerative diseases such as Alzheimer's disease.
Pharmacology[edit]
Hemicholinium-3 is not used therapeutically due to its potent inhibitory effects on acetylcholine synthesis. Its primary use is in experimental settings to study the dynamics of cholinergic neurotransmission.
Safety and Handling[edit]
As a research chemical, HC-3 should be handled with care. Appropriate safety measures, including the use of personal protective equipment (PPE), should be followed to avoid exposure.
Related Compounds[edit]
- Vesamicol - another inhibitor that affects acetylcholine storage.
- Physostigmine - an acetylcholinesterase inhibitor that increases acetylcholine levels.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian